FATE THERAPEUTICS INC (FATE) Institutional Ownership Changes & 13F Activity
FATE THERAPEUTICS INC (FATE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, T. Rowe Price Investment Management, Inc., Aqr Capital Management Llc, Goldman Sachs Group Inc, and Qube Research & Technologies Ltd.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Integrated Wealth Concepts Llc | Buy | +237 | +1.6% | 15,183 | $40.99K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +50,382 | +5.3% | 993,308 | $2.68M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +36,650 | +122.7% | 66,515 | $179.59K | Q2 2026 | Aug 27, 2026 |
| Assenagon Asset Management S.A. | Sell | -44,414 | -23.3% | 145,838 | $393.76K | Q2 2026 | Aug 21, 2026 |
| Mercer Global Advisors Inc | Buy | +63,576 | +127.7% | 113,380 | $306.13K | Q2 2026 | Aug 19, 2026 |
| Jefferies Financial Group Inc. | Buy | +59,122 | — | 59,122 | $159.63K | Q2 2026 | Aug 17, 2026 |
| Proficio Capital Partners Llc | Buy | +26,252 | — | 26,252 | $70.88K | Q2 2026 | Aug 17, 2026 |
| Millennium Management Llc | Buy | +2,433,978 | — | 2,433,978 | $6.57M | Q2 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Buy | +1,080,320 | — | 1,080,320 | $2.92M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +835,708 | +27.8% | 3,837,229 | $10.36M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +721,430 | +54.3% | 2,049,187 | $5.53M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +578,150 | — | 578,150 | $1.56M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +399,109 | +925.6% | 442,228 | $1.19M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +380,028 | +58.7% | 1,027,007 | $2.77M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +338,058 | — | 338,058 | $912.76K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +265,982 | — | 265,982 | $718.15K | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Sell | -253,966 | -59.1% | 176,107 | $475.49K | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +245,814 | — | 245,814 | $663.70K | Q2 2026 | Aug 14, 2026 |
| Cerity Partners Llc | Buy | +228,188 | +201.0% | 341,732 | $854.03K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +212,554 | +71.2% | 511,050 | $1.38M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -208,343 | -53.5% | 180,826 | $488.23K | Q2 2026 | Aug 14, 2026 |
| Bruce & Co., Inc. | Buy | +200,000 | +25.3% | 989,188 | $2.67M | Q2 2026 | Aug 14, 2026 |
| Aster Capital Management (Difc) Ltd | Buy | +176,600 | — | 176,600 | $476.82K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +153,624 | — | 153,624 | $414.79K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -145,324 | -19.2% | 610,949 | $1.65M | Q2 2026 | Aug 14, 2026 |
| Hsbc Holdings Plc | Buy | +143,040 | +146.4% | 240,724 | $635.51K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +123,077 | +3.6% | 3,589,863 | $9.69M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +114,993 | +157.5% | 187,989 | $507.57K | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +113,090 | +1087.6% | 123,488 | $333.00K | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Sell | -79,000 | -33.1% | 159,650 | $431.06K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about FATE activity
Which institutional owners are buying FATE?
Institutional owners buying FATE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in FATE activity?
"Buy" means an investor increased their reported position in FATE compared to the prior reporting period. This reflects growing exposure to FATE THERAPEUTICS INC (FATE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in FATE increasing?
Institutional interest in FATE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related FATE Institutional Insights
- FATE Overview
- FATE 13F Institutional Holders
- FATE Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- FATE Insider Trading & SEC Form 4 Activity
- FATE Articles
- Top Institutional Investor Stock Rankings